Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Escalade (ESCA) Asset Writedowns and Impairment (2019 - 2025)

Escalade's Asset Writedowns and Impairment history spans 10 years, with the latest figure at $353000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 104.05% year-over-year to $353000.0; the TTM value through Dec 2025 reached $983000.0, up 31.59%, while the annual FY2025 figure was $983000.0, 31.59% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $353000.0 at Escalade, down from $405000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $405000.0 in Q3 2025 and bottomed at -$207000.0 in Q3 2021.
  • The 5-year median for Asset Writedowns and Impairment is $119500.0 (2023), against an average of $110888.9.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 332.91% in 2021 before it skyrocketed 363.33% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$184000.0 in 2021, then rose by 18.48% to -$150000.0 in 2022, then surged by 363.33% to $395000.0 in 2023, then plummeted by 56.2% to $173000.0 in 2024, then soared by 104.05% to $353000.0 in 2025.
  • Per Business Quant, the three most recent readings for ESCA's Asset Writedowns and Impairment are $353000.0 (Q4 2025), $405000.0 (Q3 2025), and $63000.0 (Q2 2025).